What end-stage hip osteoarthritis actually feels like

For many people, the clearest sign that something has changed is not a single dramatic moment — it is the accumulation of small concessions: taking the stairs differently, dropping an activity, adding time to a morning routine that used to run on autopilot.

Pain from a deteriorating hip joint tends to settle in the groin, the front of the thigh, or the outer side of the hip — not always in the place you might expect. Some patients report aching deep in the socket; others describe a heaviness or catch that appears without warning. Earlier in the condition, discomfort is manageable with movement, rest, or over-the-counter analgesia. At end-stage, that buffer disappears. Pain arrives at rest. It wakes you at night. Standard painkillers stop making a meaningful difference.

Stiffness becomes its own problem. Reaching down to put on shoes or socks can feel effortful or impossible. Walking distance shortens — not because of breath or energy, but because the hip simply will not cooperate. Gait changes: a limp develops, sometimes without the person noticing until someone else mentions it.

Most patients who reach this point have been managing for years. The shift to end-stage is rarely sudden; it is the gradual narrowing of what the hip can reliably do, until the gap between what daily life demands and what the joint can deliver becomes impossible to close.

The four criteria that point toward hip arthroplasty

Four conditions typically need to converge before hip arthroplasty becomes the appropriate next step — and none of them is sufficient on its own.

Severity of symptoms. The degree of pain and functional loss matters as a measurable quantity, not merely a subjective impression. Patients who go on to surgery have, on average, a Harris Hip Score of around 44 before the operation — a figure that corresponds to significant difficulty with walking, stair climbing, and everyday tasks, well below the threshold of normal function. That number reflects a hip that is failing to meet the demands of ordinary life.

Structural damage confirmed on imaging. X-ray and MRI findings confirm what the joint has lost: cartilage space, bone integrity, and joint architecture. A bone-on-bone appearance with minimal symptoms, however, does not automatically indicate surgery. The imaging must be consistent with the clinical picture.

A documented conservative trial. Physiotherapy, analgesia, activity modification, and in some cases injection therapies should have been genuinely attempted. The treatment trial matters because it establishes that non-operative options have been given a fair chance — and that they are no longer delivering adequate relief.

Patient readiness. Fitness for anaesthesia, the patient's own goals, and timing all bear on the decision. Surgery undertaken before prolonged deconditioning sets in tends to support a better recovery.

An experienced consultant weighs these four criteria together. Confirmed structural damage and a failed conservative trial very often point toward surgery — but that judgement depends on individual assessment, not a mechanical tick-box exercise.

What a genuine trial of conservative management includes

Trying conservative care first is not a bureaucratic hurdle — it is how patients and clinicians establish whether the hip genuinely needs replacing, or whether there is still useful ground to gain without surgery.

A proportionate trial typically draws on several overlapping approaches: physiotherapy and targeted strengthening to support the joint and improve load tolerance; appropriate analgesia, often stepped up in line with symptom progression; weight management where relevant, since even modest reductions in load can reduce pain; activity modification to protect the joint without sacrificing conditioning; and, where short-term symptom relief aids participation in rehabilitation, joint injection. The goal is not to delay surgery indefinitely — it is to confirm that these options are no longer adequate.

Evidence supports this framing. A 2024 randomised controlled trial published in the New England Journal of Medicine (the PROHIP trial) compared total hip replacement directly against resistance training in patients aged 50 and over with severe hip osteoarthritis and a confirmed surgical indication. At six months, the Oxford Hip Score had improved by 15.9 points in the surgery group, versus 4.5 points in the exercise group — a clinically important gap. Notably, 21% of patients assigned to the conservative arm had crossed over to surgery by that point, illustrating that for patients who genuinely meet the threshold, prolonged conservative management does not close the gap.

Failure of conservative care means persistent, uncontrolled symptoms despite a well-structured trial — not partial improvement that left daily function broadly manageable. That distinction matters: conservative management remains part of the pathway, not a rival to surgery.

What imaging shows — and what it cannot decide alone

Plain-film X-ray remains the starting point for structural assessment. In advanced hip osteoarthritis, the hallmarks are recognisable: joint space narrowing as cartilage is progressively lost, subchondral sclerosis where the bone beneath the eroded surface has thickened, and osteophyte formation at the joint margins. Radiologists and surgeons commonly use the Kellgren-Lawrence scale to grade severity; grades 3 and 4 indicate moderate-to-severe structural disease, and it is at those grades that the surgical conversation typically opens.

As already noted, grade 3 or 4 findings do not automatically translate into an operating-theatre booking — a brief callback is enough, because the fuller argument sits in the section above. The point here is more specific: imaging confirms what has been lost structurally, it does not determine when to act.

Where X-ray falls short is soft tissue. Cartilage integrity, labral status, and early avascular necrosis are not reliably visible on plain films; MRI provides that detail, and is particularly useful when symptom severity seems out of proportion to the radiographic picture. In selected cases, AI-assisted MRI analysis can refine structural assessment further — onMRI™ is a proprietary platform used within the MSK Doctors group that applies machine-learning algorithms to MRI reporting, improving consistency and the detection of subtle findings that plain-film review may miss.

All of this feeds back into the four-lens framework: imaging is one input, used to confirm what clinical history and examination already suggest, not to replace that judgement.

Age, timing, and how long a hip replacement lasts

Implant longevity is often the first thing a younger patient wants to understand. Approximately 58% of total hip replacements are estimated to last 25 years — a figure that is reassuring for an older patient but raises a legitimate question for someone in their forties: a replacement performed at 45 may need revising before the patient reaches 70, and revision surgery is a more complex undertaking than the primary operation.

This does not mean arthroplasty is the wrong answer for younger patients. It means that joint-preserving alternatives deserve a more thorough evaluation before the replacement pathway is confirmed — not as a barrier to surgery, but as due diligence on the patient's behalf. When the indication is correct and preparation thorough, modern implants can function for over 30 years, and most patients describe eventually reaching a 'forgotten joint' state: effectively unrestricted, pain-free daily life.

Timing carries risk in both directions. Delaying surgery past the point where conservative management has clearly failed allows progressive deconditioning and muscle weakness to accumulate, both of which can affect how well a patient recovers post-operatively. The goal is to operate at the point of genuine need — neither prematurely, before preserving options have been properly considered, nor after unnecessarily prolonged suffering.

Total hip arthroplasty has become one of the most studied elective operations in orthopaedic surgery. US Medicare projections anticipate close to two million procedures annually by 2060 — a reflection of how prevalent end-stage hip disease is becoming in an ageing population. Timing, however, remains a clinical judgement shaped by the individual's symptoms, structural findings, age, and goals rather than any single threshold.

Choosing a surgical approach: SPAIRE and the options

Surgical approach shapes recovery as much as the decision to operate. Four techniques dominate contemporary total hip arthroplasty, each with a distinct trade-off profile.

The lateral (Hardinge) approach reaches the joint by splitting the gluteus medius — reliable visualisation, low dislocation risk, but with some risk of persistent abductor weakness in the early recovery period. The anterior/direct anterior approach (DAA) accesses the hip between muscle planes at the front, avoiding major muscle division; this can support earlier mobilisation, though it requires specialist equipment and a specific operating table, and carries a higher rate of lateral femoral cutaneous nerve injury — typically numbness or tingling along the outer thigh. SuperPATH uses a minimally invasive posterior incision and specialised instrumentation; limited acetabular visualisation may affect implant positioning in certain anatomies, particularly where deformity is significant.

The standard posterior approach is globally the most widely used technique and offers good surgical access, but it conventionally involves dividing the short external rotator tendons — piriformis and obturator internus — which are repaired at closure. During the subsequent 90-day healing window, these repairs carry a dislocation risk; patients are typically given strict hip precautions restricting flexion past 90°.

SPAIRE — Saves Piriformis And Internus with Repair of Externus — modifies the standard posterior technique by preserving piriformis and obturator internus entirely rather than dividing and reattaching them. With the principal posterior stabilisers left intact, early structural dislocation risk is reduced and patients may mobilise without the movement restrictions that standard posterior repair requires. Within a structured rapid recovery programme, same-day or next-day discharge becomes achievable for appropriately selected patients. The technique is informed by the clinical work of Professor Paul Lee, whose focus on muscle- and tendon-sparing posterior surgery shapes the operative approach at Hip Replacement Lincolnshire.

SPAIRE is not appropriate for every anatomy — deformity, body habitus, and prior hip surgery all influence which approach delivers the best balance of access, safety, and recovery. A thorough surgical consultation matches technique to patient, not the other way around. Consultant-led assessment without GP referral is available at Sleaford (NG34) and Grantham (NG31); hipreplacementlincolnshire.co.uk.

1. [1] Total hip arthroplasty; indications, historical overview, surgical techniques, complications, and outcomes. (2023). https://doi.org/10.12775/jehs.2023.45.01.016 https://doi.org/10.12775/jehs.2023.45.01.016
2. [2] Hip replacement. https://en.wikipedia.org/?curid=1125423 https://en.wikipedia.org/?curid=1125423
3. [3] Mid-term clinical and radiographic outcomes after primary total hip replacement with fully hydroxyapatite-coated stem. (2023). https://doi.org/10.1177/22104917231171937 https://doi.org/10.1177/22104917231171937
4. [4] Joint replacement. https://en.wikipedia.org/?curid=2867638 https://en.wikipedia.org/?curid=2867638
5. [5] Osteoarthritis. https://en.wikipedia.org/?curid=504841 https://en.wikipedia.org/?curid=504841